Amanote Research
Register
Sign In
Sirtuin 2 (SIRT2)
Science-Business eXchange
doi 10.1038/scibx.2012.985
Full Text
Open PDF
Abstract
Available in
full text
Date
September 1, 2012
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Highly Potent Inhibitors of Sirtuin 1 (SIRT1), SIRT2 and SIRT3
Science-Business eXchange
Dysregulation of Sirtuin 2 (SIRT2) and Histone H3K18 Acetylation Pathways Associates With Adverse Prostate Cancer Outcomes
BMC Cancer
Cancer Research
Oncology
Genetics
N, N-Bisbenzylidenebenzene-1, 4-Diamines and N, N-Bisbenzylidenenaphthalene-1, 4-Diamines as Sirtuin Type 2 (SIRT2) Inhibitors
Sirtuin 1 and Sirtuin 3: Physiological Modulators of Metabolism
Physiological Reviews
Medicine
Physiology
Molecular Biology
Sirtuin 1 (SIRT1)
Science-Business eXchange
SIRT2 Mediates Multidrug Resistance in Acute Myelogenous Leukemia Cells via ERK1/2 Signaling Pathway
International Journal of Oncology
Cancer Research
Oncology
Sirtuin 1 (SIRT1)
Journal of Biomolecular Screening
Molecular Medicine
Pharmacology
Biochemistry
Analytical Chemistry
Biotechnology
Drug Discovery
Discovering Inhibitors of Human Sirtuin Type 2: Novel Structural Scaffolds
Sirtuin 1 (SIRT1)
Science-Business eXchange